Editorial: Bivalirudin with post-procedural infusion: Should the Guidelines change to keep up with the data?
Cardiovasc Revasc Med
.
2023 Dec:57:80-81.
doi: 10.1016/j.carrev.2023.08.002.
Epub 2023 Aug 10.
Author
Michael J Lipinski
1
Affiliation
1
Cardiovascular Associates of Charlottesville and Sentara Martha Jefferson Hospital, Charlottesville, VA, United States of America. Electronic address: mjlipinski12@gmail.com.
PMID:
37661529
DOI:
10.1016/j.carrev.2023.08.002
No abstract available
Publication types
Editorial
MeSH terms
Antithrombins* / adverse effects
Hirudins* / adverse effects
Humans
Peptide Fragments / adverse effects
Substances
bivalirudin
Hirudins
Antithrombins
Peptide Fragments